Form 4: Accolade Inc. Executive Richard Eskew Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Accolade Inc.'s EVP General Counsel, Richard Eskew, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

  • Richard Eskew, EVP General Counsel at Accolade, Inc., filed a Form 4 detailing recent transactions involving the company's stock.
  • On December 2, 2024, Eskew acquired 11,841 shares of common stock through the vesting of restricted stock units (RSUs).
  • These RSUs vested in three tranches: 389, 758, and 10,694 shares.
  • On December 3, 2024, Eskew sold 3,581 shares at a price of $3.595 per share.
  • The sale was to cover tax withholding obligations related to the vesting of the RSUs and was not a discretionary transaction.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the stock ownership changes of company executives.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
  • The vesting schedules and tax withholding practices described are typical for RSU grants in the technology sector.
  • Similar filings can be seen from executives at comparable companies such as Teladoc Health and Livongo, which also use equity compensation.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they represent a small portion of the total outstanding shares.
  • The sale of shares to cover tax obligations is a standard practice and does not indicate any change in the executive's confidence in the company.

Key Dates

DateDescription
06/01/2021June 2021 Vesting Commencement Date for some of the RSUs.
06/01/2023Vesting commencement date for some of the RSUs granted on June 27, 2023.
06/27/2023Date of grant for some of the restricted stock units.
12/02/2024Date of RSU vesting and acquisition of common stock.
12/03/2024Date of sale of common stock to cover tax obligations.
12/04/2024Date of signature on the Form 4 filing.

Keywords

Form 4, Accolade Inc., Richard Eskew, Restricted Stock Units, RSU, Stock Transaction, Vesting, Tax Withholding, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.